- ►bloodjournal.org [PDF] KA Foon, RF Todd… - Blood, 1986 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ... Cited by 596 - Related articles - All 4 versions
- ►jcojournal.org [PDF] RO Dillman, R Mick, OR McIntyre - Journal of Clinical Oncology, 1989 - jcojournal.org From the University of California San Diego School of Medicine, La Jolla; Harvard School of
Public Health, Boston; and Norris Cotton Cancer Center, Hanover, NH. Submitted August 1,
1988; accepted November 16, 1988. This study was conducted by the Cancer and ... Cited by 107 - Related articles - All 6 versions
- ►hematologylibrary.org [PDF] JS Lee, DO Dixon, HM Kantarjian, MJ … - …, 1987 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ... Cited by 95 - Related articles - All 5 versions
- ►oxfordjournals.org [PDF] PL Olive, JP Banath, RE Durand - JNCI Journal of the National …, 1990 - jnci.oxfordjournals.org (7) GALE RP, FOON KA: Chronic lymphocytic leu- kemia: Recent advances in biology and
treat- ment. Ann Intern Med 103:101-120, 1985 (2) HILL BT: Studies on the transport and cellular
distribution of chlorambucil in the Yoshida ascites sarcoma. Biochem Pharmacol 21: 495- ... Cited by 85 - Related articles - All 6 versions
- ►rupress.org [PDF] T Wen, H Mellstedt, M Jondal - Journal of Experimental Medicine, 1990 - jem.rupress.org Chronic B lymphocytic leukemia (B-CLL)' and multiple myeloma (MM) repre- sent malignancies
at different stages ofB cell differentiation. In B-CLL the majority of the cells have characteristics
of immature B lymphocytes, whereas in MM the main part oftumorclone consists of end ... Cited by 67 - Related articles - All 3 versions
- ►bloodjournal.org [PDF] S Raghoebier, JH Van Krieken, JC Kluin-Nelemans, A … - Blood, 1991 - Am Soc Hematology . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 62 - Related articles - All 4 versions
B Falini, S Pileri, MF Martelli - Critical reviews in oncology/hematology, 1989 - ncbi.nlm.nih.gov Morphological and immunological characteristics of lymphoproliferative diseases are
reviewed. In particular, a basic distinction is made between non-Hodgkin's lymphomas and Hodgkin's
disease. As to the non-Hodgkin's lymphomas, emphasis is given to the problems of ... Cited by 45 - Related articles - All 2 versions
AG Bosanquet, PB Bell - Leukemia research, 1996 - Elsevier Ex vivo drug sensitivity testing is of considerable benefit in aiding the choice of optimum chemotherapy
for leukaemia patients, especially when several therapeutic options exist, eg for relapsed chronic
lymphocytic leukaemia (CLL). We have used the Differential Staining Cytotoxicity (DiSC) ... Cited by 41 - Related articles - BL Direct - All 5 versions
- ►hematologylibrary.org [PDF] AG Bosanquet, PB Bell - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 40 - Related articles - BL Direct - All 3 versions
AA Hertler, DM Schlossman, MJ Borowitz, HE … - Int J Cancer, 1989 - interscience.wiley.com Five patients with B-cell chronic lymphocytic leukemia (B-CLL) were treated with 6 courses of
the anti-CD5 immunotoxin T101-ricin A chain (T101-RTA). Each course consisted of 8 bi-weekly
infusions of T101-RTA (7 or 14 mg/m 2 ). The immunotoxin was well tolerated in all cases ... Cited by 40 - Related articles - All 3 versions
